Established in April 2020, the Kyoto University Center for Cancer Immunotherapy and Immunobiology (CCII) is devoted to advancing immunology and cancer research with the aim of transforming the society through science.
The mission of CCII is to become a world leading research institute fostering discoveries that will enable us to control and conquer cancer and other diseases by harnessing the power of the immune system.
We aim to create a vibrant scientific environment -Conducive, Collaborative, Inclusive and International- empowering researchers to pursue original scientific questions in cancer immunotherapy and immunobiology, and establish stimulating collaboration networks with leading institutions worldwide.
We continue the research to fulfill our dream that most of the cancers will be controlled through sophisticated yet widely available immune system interventions by 2050.
We therefore envision an integrative, holistic approach to understanding the physiology of health and disease, aided by systems biology approaches and cutting edge medical technology and bioinformatics.
We bring together basic scientific research with medical disciplines to collaborate in exploring the evolving status of the immune system during cancer development, as well as how it affects other major physiological functions in the nervous, endocrine, circulatory and gastro-intestinal systems. We hope our central values of Cooperation and Competitiveness, Integrity and Innovation will encourage students and early career researchers to engage with pioneering work in new, integrated fields of medical knowledge.